Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMEA Finalizes Framework To Expedite Scientific Advice

This article was originally published in The Pink Sheet Daily

Executive Summary

New framework includes pre-submission meetings on issues that fall outside the scope of scientific advice.

You may also be interested in...



Scientific Advice Meetings To Address More General Topics, MHRA says

Initiative aims to address issues “where no definitive answers may be possible.”

Scientific Advice Meetings To Address More General Topics, MHRA says

Initiative aims to address issues “where no definitive answers may be possible.”

FDA, EMEA To Hold Joint Scientific Advice Meetings With Sponsors

One-year pilot program will launch in January to address specific development issues for breakthrough products. Meetings will provide an "opportunity to optimize product development" and are expected to help avoid unnecessary replication or divergence in agency methodologies, FDA and EMEA say.

Related Content

Topics

UsernamePublicRestriction

Register

PS064213

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel